← back to search

Julia Bielicki

University of Lausanne · CH
🔎 Find collaborators in Applied Microbiology and Biotechnology · Pharmacology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Applied Microbiology and Biotechnology · Pharmacology
Research interest
Research interests include Antibiotic Use and Resistance, Antibiotics Pharmacokinetics and Efficacy, Neonatal and Maternal Infections, and Pharmaceutical studies and practices.
h-index
44
citations
30,077
works
260
NIH funding
primary concept
Medicine
email

Recent publications

Kangaroo Care as an intervention in randomised controlled trials in neonatal intensive care.
2026cited by 0position: contributordoi
Improving Registration and Dataflows Between Pediatric Oncology Clinics and the Childhood Cancer Registry of Switzerland: Protocol for SwissPedCancer Quality Assurance Study.
2026cited by 0position: contributordoi
Long-term assessment of developmental outcomes of newborn babies with sepsis
http://isrctn.com/ 2026cited by 0position: contributordoi
Antimicrobial Stewardship Antimicrobial Stewardship
DGPI Handbuch 2026cited by 0position: contributordoi
Availability and Quality of Anthropometric Data in Swiss Children’s Hospitals: The SwissPedGrowth Project
2026cited by 0position: contributordoi
Pneumonie
DGPI Handbuch 2026cited by 0position: contributordoi
Infektionsprävention Infektionsprävention
DGPI Handbuch 2026cited by 0position: contributordoi
All-cause mortality and infection-related outcomes of hospital-initiated kangaroo care versus conventional neonatal care for low-birthweight infants: a systematic review and meta-analysis
The Lancet Child & Adolescent Health 2025cited by 13position: lastdoi
Sense and Nonsense of Bacterial Decolonization in Neonatal Care.
2025cited by 0position: contributordoi
Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: systematic review and meta-analysis
2025cited by 0position: contributordoi
Safety and efficacy of antiseptic cleansing to reduce vertical transmission of multi-drug resistant pathogens to neonates (NeoVT-AMR)
2025cited by 0position: contributordoi
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
2024cited by 335position: contributordoi
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
2024cited by 199position: contributordoi
Vaccine value profile for Klebsiella pneumoniae
Vaccine 2024cited by 61position: middledoi
Vaccine value profile for Klebsiella pneumoniae.
2024cited by 53position: contributordoi
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework
The Lancet Microbe 2024cited by 17position: middledoi
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
2024cited by 16position: contributordoi
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
2024cited by 9position: contributordoi
Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial.
2024cited by 6position: contributordoi
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland.
2024cited by 6position: contributordoi
Implementation of infection prevention and control for hospitalized neonates: A narrative review.
2024cited by 6position: contributordoi
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collection.
2024cited by 6position: contributordoi
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.
2024cited by 5position: contributordoi
Tackling inappropriate antibiotic use in low-and middle-income countries.
2024cited by 2position: contributordoi
Electronic hand hygiene monitoring tools for implementation of optimal hand sanitizing adherence in neonatal intensive care.
2024cited by 2position: contributordoi
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization.
2024cited by 1position: contributordoi
Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland.
2024cited by 1position: contributordoi
Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study.
2024cited by 1position: contributordoi
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland.
2024cited by 1position: contributordoi
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
2024cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 25 papers (2019–2026)Yingfen Hsia · St George's, University of London16 papers (2019–2021)Adrian Egli · University of Zurich16 papers (2020–2024)Mike Sharland · St George's, University of London14 papers (2015–2025)Roland Bingisser · OLVG11 papers (2020–2022)Hans H. Hirsch · Vir Biotechnology (Switzerland)11 papers (2020–2022)Paul T. Heath · NIHR Southampton Biomedical Research Centre10 papers (2019–2023)Angela Dramowski · Western Cape Department of Health9 papers (2019–2024)Sarah Tschudin-Sutter · University of Basel9 papers (2020–2023)A. Sarah Walker · The Royal Free Hospital8 papers (2019–2024)Petra Zimmermann · University of Fribourg8 papers (2021–2024) · 8 papers (2020–2024) · 8 papers (2020–2022)Luregn J. Schlapbach · The University of Queensland8 papers (2022–2026)Saul N. Faust · University of Nottingham7 papers (2019–2024)Alfredo Mari · Springer Nature7 papers (2020–2022)Helena M. B. Seth-Smith · SIB Swiss Institute of Bioinformatics7 papers (2020–2024)Carlo Giaquinto · University of Padua7 papers (2019–2022) · 6 papers (2019–2025)Christoph Berger · University Centre of Legal Medicine6 papers (2020–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Applied Microbiology and Biotechnology · Pharmacology →